Cws Financial Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Cws Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $74,276 - $83,127	382 New	382 $74,000
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $205,979 - $261,323	1,045 New	1,045 $227,000
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $339,784 - $433,873	-967 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$294.17 - $371.65 $22,945 - $28,988	-78 Reduced 7.46%	967 $358,000
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $2,247 - $2,695	9 Added 0.87%	1,045 $303,000
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $2,664 - $3,031	12 Added 1.17%	1,036 $259,000
Q3 2020 Nov 10, 2020	BUY	$175.56 - $226.45 $179,773 - $231,884	1,024 New	1,024 $232,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Cws Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cws Financial Advisors, LLC with notifications on news.